PubMed:1498419 / 93-298 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":205},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":205},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":205},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}

{"project":"GlycoBiology-FMA","denotations":[{"id":"_T4","span":{"begin":71,"end":74},"obj":"FMAID:167182"},{"id":"_T5","span":{"begin":81,"end":91},"obj":"FMAID:167180"},{"id":"_T6","span":{"begin":115,"end":127},"obj":"FMAID:167256"},{"id":"_T7","span":{"begin":115,"end":127},"obj":"FMAID:62925"},{"id":"_T8","span":{"begin":135,"end":142},"obj":"FMAID:146300"},{"id":"_T9","span":{"begin":135,"end":142},"obj":"FMAID:50594"},{"id":"_T10","span":{"begin":135,"end":149},"obj":"FMAID:25456"},{"id":"_T11","span":{"begin":135,"end":149},"obj":"FMAID:117867"},{"id":"_T12","span":{"begin":135,"end":149},"obj":"FMAID:167552"},{"id":"_T13","span":{"begin":135,"end":149},"obj":"FMAID:63163"},{"id":"_T14","span":{"begin":135,"end":149},"obj":"FMAID:25320"},{"id":"_T15","span":{"begin":135,"end":149},"obj":"FMAID:118168"},{"id":"_T16","span":{"begin":135,"end":149},"obj":"FMAID:117967"},{"id":"_T17","span":{"begin":135,"end":149},"obj":"FMAID:25241"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}

{"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":100,"end":111},"obj":"http://www.uniprot.org/uniprot/Q6UXC5"},{"id":"T8","span":{"begin":184,"end":187},"obj":"http://www.uniprot.org/uniprot/Q96RI9"}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}

{"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T2","span":{"begin":164,"end":173},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/166034"}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}

{"project":"GO-BP","denotations":[{"id":"T2","span":{"begin":61,"end":70},"obj":"http://purl.obolibrary.org/obo/GO_0046903"}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}

{"project":"GO-MF","denotations":[{"id":"T2","span":{"begin":81,"end":91},"obj":"http://purl.obolibrary.org/obo/GO_0003823"}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}

{"project":"GO-CC","denotations":[{"id":"T1","span":{"begin":174,"end":178},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}

{"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T1","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G41652MJ\""},{"id":"GlycanIUPAC_T3","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G20761YC\""},{"id":"GlycanIUPAC_T5","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G19807HM\""},{"id":"GlycanIUPAC_T7","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G20351TE\""},{"id":"GlycanIUPAC_T9","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G71957MR\""},{"id":"GlycanIUPAC_T11","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G59040AE\""},{"id":"GlycanIUPAC_T13","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G14987PW\""},{"id":"GlycanIUPAC_T15","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G95064PC\""},{"id":"GlycanIUPAC_T17","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G39143AQ\""},{"id":"GlycanIUPAC_T19","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G65149OO\""},{"id":"GlycanIUPAC_T21","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G02766SY\""},{"id":"GlycanIUPAC_T23","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G26019KJ\""},{"id":"GlycanIUPAC_T25","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G36429CZ\""},{"id":"GlycanIUPAC_T27","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G89633TP\""},{"id":"GlycanIUPAC_T29","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G28494FO\""},{"id":"GlycanIUPAC_T31","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G06219CP\""},{"id":"GlycanIUPAC_T33","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G44237SM\""},{"id":"GlycanIUPAC_T35","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G57948RL\""},{"id":"GlycanIUPAC_T37","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G64016DN\""},{"id":"GlycanIUPAC_T39","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G14536PC\""},{"id":"GlycanIUPAC_T41","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G14356FW\""},{"id":"GlycanIUPAC_T43","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G34565UO\""},{"id":"GlycanIUPAC_T45","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G67124MW\""},{"id":"GlycanIUPAC_T47","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G71457ZU\""},{"id":"GlycanIUPAC_T49","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G55228VZ\""},{"id":"GlycanIUPAC_T51","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G31034MJ\""},{"id":"GlycanIUPAC_T53","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G25776IP\""},{"id":"GlycanIUPAC_T55","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G64442BV\""},{"id":"GlycanIUPAC_T57","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G57018LE\""},{"id":"GlycanIUPAC_T59","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G61761GX\""},{"id":"GlycanIUPAC_T61","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G76318UX\""},{"id":"GlycanIUPAC_T63","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G61906ER\""},{"id":"GlycanIUPAC_T65","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G68723GR\""},{"id":"GlycanIUPAC_T67","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G19540LE\""},{"id":"GlycanIUPAC_T69","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G74944PO\""},{"id":"GlycanIUPAC_T71","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G89489ZJ\""},{"id":"GlycanIUPAC_T73","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G04434YU\""},{"id":"GlycanIUPAC_T75","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G21450PB\""},{"id":"GlycanIUPAC_T77","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G93629QY\""},{"id":"GlycanIUPAC_T79","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G02603TR\""},{"id":"GlycanIUPAC_T81","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G40280JP\""},{"id":"GlycanIUPAC_T83","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G95259IC\""},{"id":"GlycanIUPAC_T85","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G26900FE\""},{"id":"GlycanIUPAC_T87","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G21346KK\""},{"id":"GlycanIUPAC_T89","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G62509FF\""},{"id":"GlycanIUPAC_T91","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G83932AK\""},{"id":"GlycanIUPAC_T93","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G96978IB\""},{"id":"GlycanIUPAC_T95","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G34275DN\""},{"id":"GlycanIUPAC_T97","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G07071JF\""},{"id":"GlycanIUPAC_T99","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G80639QD\""},{"id":"GlycanIUPAC_T101","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G99460PJ\""},{"id":"GlycanIUPAC_T103","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G22024BZ\""},{"id":"GlycanIUPAC_T105","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G74097ZY\""},{"id":"GlycanIUPAC_T107","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G84439YP\""},{"id":"GlycanIUPAC_T109","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G52207WQ\""},{"id":"GlycanIUPAC_T111","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G90695MS\""},{"id":"GlycanIUPAC_T113","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G50398QX\""},{"id":"GlycanIUPAC_T115","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G12166ZT\""},{"id":"GlycanIUPAC_T117","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G48368BR\""},{"id":"GlycanIUPAC_T119","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G57407RW\""},{"id":"GlycanIUPAC_T121","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G00386TY\""},{"id":"GlycanIUPAC_T123","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G18723JK\""},{"id":"GlycanIUPAC_T125","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G93757OR\""},{"id":"GlycanIUPAC_T127","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G29006SI\""},{"id":"GlycanIUPAC_T129","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G03099OQ\""},{"id":"GlycanIUPAC_T131","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G53739OW\""},{"id":"GlycanIUPAC_T133","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G70440ZO\""},{"id":"GlycanIUPAC_T135","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G29951RR\""},{"id":"GlycanIUPAC_T137","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G58402TI\""},{"id":"GlycanIUPAC_T139","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G39875TP\""},{"id":"GlycanIUPAC_T141","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G83439QV\""},{"id":"GlycanIUPAC_T143","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G41762RC\""},{"id":"GlycanIUPAC_T145","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G91604UI\""},{"id":"GlycanIUPAC_T147","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G88447WE\""},{"id":"GlycanIUPAC_T149","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G93634BS\""},{"id":"GlycanIUPAC_T151","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G02587BH\""},{"id":"GlycanIUPAC_T153","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G43511MX\""},{"id":"GlycanIUPAC_T155","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G64958DH\""},{"id":"GlycanIUPAC_T157","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G30384TR\""},{"id":"GlycanIUPAC_T159","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G15624EX\""},{"id":"GlycanIUPAC_T161","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G22706ST\""},{"id":"GlycanIUPAC_T163","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G57408PI\""},{"id":"GlycanIUPAC_T165","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G86403XX\""},{"id":"GlycanIUPAC_T167","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G78043YB\""},{"id":"GlycanIUPAC_T169","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G18952JK\""},{"id":"GlycanIUPAC_T171","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G49020ND\""},{"id":"GlycanIUPAC_T173","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G63590YW\""},{"id":"GlycanIUPAC_T175","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G22793KS\""},{"id":"GlycanIUPAC_T177","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G64134SS\""},{"id":"GlycanIUPAC_T179","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G17338HY\""},{"id":"GlycanIUPAC_T181","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G99745XF\""},{"id":"GlycanIUPAC_T183","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G27782HN\""},{"id":"GlycanIUPAC_T185","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G57496DC\""},{"id":"GlycanIUPAC_T187","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G93169WB\""},{"id":"GlycanIUPAC_T189","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G05518TD\""},{"id":"GlycanIUPAC_T191","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G62603DN\""},{"id":"GlycanIUPAC_T193","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G59574FS\""},{"id":"GlycanIUPAC_T195","span":{"begin":57,"end":60},"obj":"\"http://rdf.glycoinfo.org/glycan/G47567WC\""}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}

{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":156,"end":173},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0004989"}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T1","span":{"begin":164,"end":173},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0030731"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}

{"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":150,"end":155},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"10088"},{"id":"A2","pred":"db_id","subj":"T1","obj":"10090"}],"text":"The preparation of greater than 30 different hybridomas, all secreting IgM class antibodies against epiglycanin, a glycoprotein at the surface of the mouse mammary carcinoma cell line TA3-Ha, is described."}